SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PSDV - pSivida Limited
An SI Board Since November 2005
Posts SubjectMarks Bans Symbol
421 8 0 PSDV
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
246Hi Arthur We both know that rec. means _NADA_ The "table" is in a John McCarthy-11/18/2009
245John, You certainly have kept the faith on this little booger! (:>) Hope it tArthur Radley-11/18/2009
244Ladenburg Thalmann Initiates Coverage on pSivida (PSDV) with a Buy November 18John McCarthy-11/18/2009
243My notes from CC (a) December is still the anticipated date for the P3 trial reJohn McCarthy-11/12/2009
242Ohr Pharmaceutical (OTCBB: OHRP) CEO Announces Completion of Biotech TransformatJohn McCarthy-11/11/2009
241Long-term vision for Intersouth-backed Alimera Sciences could be cloudy Mon., NJohn McCarthy-11/11/2009
240Alimera Sciences refiles for IPO November 2, 2009 ATLANTA - Alimera Sciences InJohn McCarthy-11/2/2009
239Alimera Sciences Inc., an Atlanta-based ophthalmic pharmaceutical company, <John McCarthy-11/1/2009
238IOP spikes after Avastin therapy may be attributable to differences in how dosesJohn McCarthy-11/1/2009
237AAO: Intravitreal Shots Carry Risk of Persistent Glaucoma SAN FRANCISCO -- IntrJohn McCarthy-11/1/2009
236Ranibizumab Can Help Patients With Age-Related Macular Degeneration and DiabeticJohn McCarthy-11/1/2009
235Study links anti-VEGF use with elevated IOP SAN FRANCISCO — Anti-VEGF treatmentJohn McCarthy-11/1/2009
234Photodynamic Therapy No Help in Treating Macular Degeneration SAN FRANCISCO -- John McCarthy-11/1/2009
233CMS to reverse ruling on bevacizumab reimbursement starting in 2010 The CentersJohn McCarthy-11/1/2009
232Hi Arthur Some guys on the Yahoo board are ALSO saying they got a phone call. John McCarthy-10/21/2009
231John, Go figure..........announce good news and the stock goes down. I did get Arthur Radley-10/21/2009
230pSivida Announces Completion of BrachySil Dose Ranging Study in Pancreatic CanceJohn McCarthy-10/21/2009
229reuters.comArthur Radley-10/15/2009
228Omega 3 - continuation of previous post 3 Long-chain polyunsaturated fatty aciJohn McCarthy-10/11/2009
227Study shows omega-3 may prevent age-related sight loss (See next post for studyJohn McCarthy-10/11/2009
226Despite Lucentis's effectiveness-- ** VISION LOSS = 90% ** VISION RESTORATIJohn McCarthy-10/11/2009
225SurModic deal with pharmaceutical giant Roche a boon to Birmingham By Michael TJohn McCarthy-10/9/2009
224Cancer drug is no different in effectiveness as gold standard treatment for macuJohn McCarthy-10/9/2009
223OT - Lpath, Inc. (OTCBB: LPTN) - WET-AMD <B>iSONEP is the ocular formulatJohn McCarthy-10/9/2009
222Event Scoreboard -- <b>(a) Lucentis does WELL in RVO trials</b> ---John McCarthy-10/7/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News